...
首页> 外文期刊>Cancer: A Journal of the American Cancer Society >High control rates of proton‐ and carbon‐ion–beam treatment with intensity‐modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center
【24h】

High control rates of proton‐ and carbon‐ion–beam treatment with intensity‐modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center

机译:在Heidelberg离子束治疗中心的101例颅底骨膜瘤患者中具有强度调制的活性光栅扫描的质子和碳离子束治疗的高控制率

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND The current study compares the results of irradiation with protons and irradiation with carbon ions via a raster scan technique in patients with G1 and G2 skull base chondrosarcomas. METHODS Between 2009 and 2014, a total of 101 patients (40 men and 61 women) with a median age of 44 years (range, 19‐77 years) were irradiated with carbon ions (79 patients) or protons (22 patients) via a raster scan technique at the Heidelberg Ion Beam Therapy Center. The median total dose was 60 Gy (relative biological effectiveness [RBE]) at 3 Gy per fraction for carbon ions and 70 Gy (RBE) at 2 Gy per fraction for protons. The median boost planning target volume was 38 cm 3 (range, 8‐133 cm 3 ). Overall survival (OS) and local control (LC) were evaluated with the Kaplan‐Meier method. RESULTS The median follow‐up period was 40 months (range, 0.8‐78.1 months). At the start of the irradiation, all patients had residual macroscopic tumors. Five patients (5%) developed a local recurrence during the follow‐up. The 1‐, 2‐, and 4‐year LC rates were 100%, 100%, and 100%, respectively, for protons and 98.6%, 97.2%, and 90.5%, respectively, for carbon ions. The OS rates during the same periods of time were 100%, 100%, and 100%, respectively, for protons and 100%, 98.5%, and 92.9%, respectively, for carbon ions. An age ≤ 44 years was associated with a trend for a better outcome. No toxicity worse than Common Toxicity Criteria grade 3 was observed after treatment. CONCLUSIONS No significant difference between carbon ions and protons in the therapy of skull base chondrosarcoma could be detected in these initial retrospective results. Cancer 2018;124:2036‐44 . ? 2018 American Cancer Society .
机译:背景技术目前的研究将用质子和碳离子照射的结果与G1和G2颅底的患者的光栅扫描技术进行比较和用碳离子辐射。 2009年至2014年期间,共有101名患者(40名男性和61名女性),中位数为44岁(范围,19-77岁)用碳离子(79名患者)或质子(22名患者)通过A辐照Heidelberg离子束治疗中心的光栅扫描技术。中值总剂量为60μg(相对生物有效性[RBE])在每馏碳离子和70GY(RBE)的3GY下为70GY(RBE),每馏分为质子。中位升压计划目标体积为38厘米3(范围,8-133厘米3)。通过Kaplan-Meier方法评估总存活(OS)和局部控制(LC)。结果中位后续期间为40个月(范围,0.8-78.1个月)。在辐照开始时,所有患者都有残留的宏观肿瘤。五名患者(5%)在随访期间发育了局部复发。对于碳离子,1-,2-和4年的LC率分别为质子和98.6%,98.6%,97.2%和90.5%。对于质子和100%,98.5%和92.9%,同期的OS速率分别为100%,100%和100%,分别用于碳离子。年龄≤44年与更好的结果有关。在治疗后,没有比常见的毒性标准级比常见毒性标准较差。结论在这些初始回顾性结果中,可以检测颅底骨膜菌治疗中碳离子和质子之间的显着差异。癌症2018; 124:2036-44。还2018年美国癌症协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号